Virbac SA (VRBCF)
OTCMKTS · Delayed Price · Currency is USD
436.32
+90.32 (26.10%)
At close: Dec 2, 2025
Virbac Employees
Virbac had 6,365 employees as of December 31, 2024. The number of employees increased by 906 or 16.60% compared to the previous year.
Employees
6,365
Change (1Y)
906
Growth (1Y)
16.60%
Revenue / Employee
$264,350
Profits / Employee
$24,545
Market Cap
3.54B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 6,365 | 906 | 16.60% |
| Dec 31, 2023 | 5,459 | 73 | 1.36% |
| Dec 31, 2022 | 5,386 | 266 | 5.20% |
| Dec 31, 2021 | 5,120 | 213 | 4.34% |
| Dec 31, 2020 | 4,907 | 10 | 0.20% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
Virbac News
- 6 days ago - Virbac : Declaration of the number of shares and voting rights 01/2026 - GlobeNewsWire
- 2 months ago - Virbac (VRBCF) Acquires Feline Hyperthyroidism Treatment for £100M - GuruFocus
- 2 months ago - Virbac expands pet health portfolio with £100M acquisition of feline hyperthyroidism drug from Norbrook - Seeking Alpha
- 2 months ago - Virbac : Declaration of the number of shares and voting rights 11/2025 - GlobeNewsWire
- 4 months ago - VIRBAC Announces Third Quarter 2025 Sales - GlobeNewsWire
- 5 months ago - Virbac SA 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 5 months ago - Virbac SA (VRBCF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 5 months ago - Virbac: 2025 Half-year results - GlobeNewsWire